uftoral has been researched along with Cancer of Head in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, M | 1 |
| Fujii, M; Imanishi, Y; Kanke, M; Ohno, Y; Tokumaru, Y | 1 |
| Belón, J; Blanco, E; Espinosa, E; Feliu, J; Garcia Alfonso, P; Garcia Girón, C; Garrido, P; González Barón, M; Jara, C; Ruiz, A; Vincent, JM; Zamora, P | 1 |
| Chida, E; Fujii, M; Fukuda, S; Furuta, Y; Inuyama, Y; Kanzaki, J; Nagahashi, T; Shirato, H; Yagi, K | 1 |
| Colevas, AD | 1 |
| Diaz-Rubio, E; Garcia Carbonero, I; González-Larriba, JL; Perez Segura, P; Sastre Valera, J | 1 |
3 review(s) available for uftoral and Cancer of Head
| Article | Year |
|---|---|
[Comparative clinical studies for head and neck cancer in Japan].
Topics: Antineoplastic Agents; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Drug Combinations; Head and Neck Neoplasms; Humans; Japan; Tegafur; Uracil | 2002 |
The role of chemotherapy in the treatment of head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Maxillary Sinus Neoplasms; Peplomycin; Survival Rate; Tegafur; Uracil | 1997 |
Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Clinical Trials as Topic; Drug Combinations; Forecasting; Head and Neck Neoplasms; Humans; Neoplasm Staging; Tegafur; Uracil | 1997 |
3 trial(s) available for uftoral and Cancer of Head
| Article | Year |
|---|---|
[Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 1996 |
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Head and Neck Neoplasms; Humans; Leucovorin; Lung Neoplasms; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1997 |
Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Drug Combinations; Female; Fluorouracil; Forecasting; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1997 |